Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

SELL
$0.46 - $1.3 $59,428 - $167,949
-129,192 Reduced 68.69%
58,883 $35,000
Q4 2022

Feb 15, 2023

BUY
$0.29 - $0.57 $16,873 - $33,164
58,184 Added 44.79%
188,075 $73,000
Q3 2022

Nov 07, 2022

BUY
$0.53 - $1.9 $68,842 - $246,792
129,891 New
129,891 $69,000

About Tonix Pharmaceuticals Holding Corp.


  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $21.7M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.